Radiolabeled GX1 Peptide for Tumor Angiogenesis Imaging
Journal Article
·
· Applied Biochemistry and Biotechnology
- Institute of Energy and Nuclear Research, Radiopharmacy Center (Brazil)
- Institute of Energy and Nuclear Research, Radiation Technology Center (Brazil)
- Butantan Institute, Laboratory of Biopharmacology in Animal Cells (Brazil)
Early and accurate detection of primary or metastatic tumors is of great value in staging, treatment management, and prognosis. Tumor angiogenesis plays an essential role in the growth, invasion, and metastatic spread of solid cancers, and so, is a promising approach for tumor imaging. The GX1 (CGNSNPKSC) peptide was identified by phage display library and has been investigated as a marker for human cancers. This study aims to evaluate the {sup 99m}Tc-HYNIC-PEG{sub 4}-c (GX1) as a biomarker for tumor imaging. Our results showed that GX1 specifically binds to tumor cells in vitro. SKMEL28 and MDA-MB231 cells achieved total binding peak at 60 min of incubation. For B16F10 and MKN45 cells, the total and specific binding were similar during all time points, while A549 cell line showed rapid cellular total uptake of the tracer at 30 min of incubation. Biodistribution showed low non-specific uptakes and rapid renal excretion. Melanoma tumors showed enhanced GX1 uptake in animal model at 60 min, and it was significantly blocked by cold peptide. The radiotracer showed tumor specificity, especially in melanomas that are highly vascularized tumors. In this sense, it should be considered in future studies, aiming to evaluate degree of angiogenesis, progression, and invasion of tumors.
- OSTI ID:
- 22848261
- Journal Information:
- Applied Biochemistry and Biotechnology, Journal Name: Applied Biochemistry and Biotechnology Journal Issue: 4 Vol. 185; ISSN ABIBDL; ISSN 0273-2289
- Country of Publication:
- United States
- Language:
- English
Similar Records
Anti-angiogenesis and anti-tumor activity of recombinant anginex
Development and Testing of a 212Pb/212Bi Peptide for Targeting Metastatic Melanoma (Final Report)
Increased iofetamine I 123 brain uptake in metastatic melanoma
Journal Article
·
Fri Oct 27 00:00:00 EDT 2006
· Biochemical and Biophysical Research Communications
·
OSTI ID:20854545
Development and Testing of a 212Pb/212Bi Peptide for Targeting Metastatic Melanoma (Final Report)
Technical Report
·
Wed Oct 24 20:00:00 EDT 2012
·
OSTI ID:1054055
Increased iofetamine I 123 brain uptake in metastatic melanoma
Journal Article
·
Sat Oct 01 00:00:00 EDT 1988
· Arch. Neurol.; (United States)
·
OSTI ID:6601470